New bone formation in a true bone ceramic scaffold loaded with desferrioxamine in the treatment of segmental bone defect: a preliminary study

2012 ◽  
Vol 17 (3) ◽  
pp. 289-298 ◽  
Author(s):  
Weibin Zhang ◽  
Guosong Li ◽  
Lianfu Deng ◽  
Shijing Qiu ◽  
Ruoxian Deng
2018 ◽  
Vol 17 (1) ◽  
Author(s):  
Nazri Mohd Yusof ◽  
Harkeerat Singh

Introduction: Segmental bone defect can be treated with autologous bone graft and bone transport. Synthetic bone graft has successfully been used for the treatment of metaphyseal fracture or bone cyst. However, their use for the treatment of segmental bone defect has not been establish. Recently, a local company has produced a biodegradable custom made synthetic bone construct phosphate-based materials that is used to treat fractures and bone defect. Materials and Methods: After getting approval from Medical Device Agency, we used SBC to treat segmental bone defect in our patients. A case series review was conducted in these cases. Results: Three patients underwent surgery using SBC as a spacer to fill the defect at the docking site to prevent soft tissue collapse in one patient and as a replacement for bone autologous bone grafting in two patients. In our observation granules resorbtion ranged from 40-80% by 6 months with no radiological evidence of new bone formation. SBC mixed with bone marrow aspirate failed to harden into a palette. Although no new bone formation was seen at the docking site, insertion of SBC prevents soft tissue invagination and reduced the need of a second surgery to remove other conventional spacers. Conclusion: SBC may be used as a spacer to prevent soft tissue interposition and skin invagination in bone transport. However mixing it with bone marrow aspirate resulted in failure to form beads and does not form bone.


Materials ◽  
2021 ◽  
Vol 14 (13) ◽  
pp. 3513
Author(s):  
Nikola Stokovic ◽  
Natalia Ivanjko ◽  
Drazen Maticic ◽  
Frank P. Luyten ◽  
Slobodan Vukicevic

Bone morphogenetic proteins (BMPs) possess a unique ability to induce new bone formation. Numerous preclinical studies have been conducted to develop novel, BMP-based osteoinductive devices for the management of segmental bone defects and posterolateral spinal fusion (PLF). In these studies, BMPs were combined with a broad range of carriers (natural and synthetic polymers, inorganic materials, and their combinations) and tested in various models in mice, rats, rabbits, dogs, sheep, and non-human primates. In this review, we summarized bone regeneration strategies and animal models used for the initial, intermediate, and advanced evaluation of promising therapeutical solutions for new bone formation and repair. Moreover, in this review, we discuss basic aspects to be considered when planning animal experiments, including anatomical characteristics of the species used, appropriate BMP dosing, duration of the observation period, and sample size.


2015 ◽  
Vol 16 (12) ◽  
pp. 12616-12630 ◽  
Author(s):  
Alexandre Kaempfen ◽  
Atanas Todorov ◽  
Sinan Güven ◽  
René Largo ◽  
Claude Jaquiéry ◽  
...  

2015 ◽  
Vol 16 (4) ◽  
pp. 615-622 ◽  
Author(s):  
Yumin Zhang ◽  
Jianru Wang ◽  
Jue Wang ◽  
Xiaojun Niu ◽  
Jianchun Liu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document